MedPath

The safety and effect of a new sweetener (Lacritose) compared to sugar and glucose on postprandial blood sugar

Phase 2
Conditions
on-insulin-dependent diabetes mellitus.
non insulin dependent diabetes mellitus
Registration Number
IRCT2015050912571N2
Lead Sponsor
Vice chancellor for research, Shahid Sadoughi University of Mecical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Type 2 diabetic patients (n=20) with fasting blood sugar >125 mg/dl and lower than 200 mg/dl, aged 20 to 60.

Exclusion criteria:
Participants will not be included in the trial if they were pregnant or lactating, had severe infection, endocrine disorders or acute diseases at the enrollment. Participants who intend to exit with any reasons or show any adverse reaction to test sugars will also be excluded from the study. .

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postprandial blood sugar. Timepoint: Every 30 minutes up to 2 hours after ingesting the test beverages. Method of measurement: Using pars azmoon kits using automated azalyzer.
Secondary Outcome Measures
NameTimeMethod
Gastrointestinal symptoms. Timepoint: 24 hour after ingesting the test beverages. Method of measurement: Gastrointestinal symptoms questionnaire.
© Copyright 2025. All Rights Reserved by MedPath